These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17353673)

  • 21. Negative T wave in chest lead V1: relation to sex and future cardiovascular risk factors.
    Onat T; Onat A; Can G
    Turk Kardiyol Dern Ars; 2008 Dec; 36(8):513-8. PubMed ID: 19223716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149(37):40. PubMed ID: 17918461
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronary heart disease and cardiovascular risk factors among people aged 25-65 years, as seen in Romanian primary healthcare.
    Bunescu DM; Stoffers HE; van den Akker M; Jan Dinant G
    Eur J Gen Pract; 2008; 14(2):56-64. PubMed ID: 18720274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enlarged waist circumference and cardiovascular risk factors].
    Pataky Z; Bobbioni-Harsch E; Makoundou V; Golay A
    Rev Med Suisse; 2009 Mar; 5(196):671-2, 674-5. PubMed ID: 19462610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic cholestasis and dyslipidemia: what is the cardiovascular risk?
    Black DD
    J Pediatr; 2005 Mar; 146(3):306-7. PubMed ID: 15756207
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperlipidaemia and cardiovascular disease: nonfasting triglycerides gain momentum--but nothing changes on the metabolic syndrome front.
    Dominiczak MH
    Curr Opin Lipidol; 2008 Jun; 19(3):326-7. PubMed ID: 18460927
    [No Abstract]   [Full Text] [Related]  

  • 27. Antihypertensive-associated incident diabetes: controversy persists.
    Gupta AK; Poulter NR
    Arch Intern Med; 2007 Jul; 167(13):1433; author reply 1434-5. PubMed ID: 17620540
    [No Abstract]   [Full Text] [Related]  

  • 28. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor.
    O'Keefe JH; Bell DS
    Am J Cardiol; 2007 Sep; 100(5):899-904. PubMed ID: 17719342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impending global epidemic of cardiovascular diseases.
    Ounpuu S; Anand S; Yusuf S
    Eur Heart J; 2000 Jun; 21(11):880-3. PubMed ID: 10806010
    [No Abstract]   [Full Text] [Related]  

  • 33. The cholesterol paradox is flawed; cholesterol must be lowered in dialysis patients.
    Wan RK; Mark PB; Jardine AG
    Semin Dial; 2007; 20(6):504-9. PubMed ID: 17991195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rubric: Viewpoint--Revue médicale de la Suisse Romande 109: 1051-1052, 1989. Response to Dr. F. Pilet].
    Rev Med Suisse Romande; 1990 Mar; 110(3):297-9. PubMed ID: 2336514
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings of the 2nd International MONICA Congress. Helsinki, Finland, August 14-15, 1987.
    Acta Med Scand Suppl; 1988; 728():1-177. PubMed ID: 3202018
    [No Abstract]   [Full Text] [Related]  

  • 37. French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors.
    Marant C; Romon I; Fosse S; Weill A; Simon D; Eschwège E; Varroud-Vial M; Fagot-Campagna A
    Diabetes Metab; 2008 Feb; 34(1):38-45. PubMed ID: 18068386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Distribution of cardiovascular risk factors in coronary patients in Sahel, Tunisia].
    Lihioui M; Boughzala E; Ben Farhat M; Ammar H; Chaouech A; Jemaa R; Kaabachi N
    East Mediterr Health J; 2007; 13(3):536-43. PubMed ID: 17687825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsomal triglyceride transfer protein inhibition-friend or foe?
    Joy TR; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):506-8. PubMed ID: 18506153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperlipidaemia and cardiovascular disease.
    Ansell BJ
    Curr Opin Lipidol; 2008 Aug; 19(4):433-4. PubMed ID: 18607193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.